Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 7,286 $ 8,968
Short-term investments 19,454 23,011
Prepaid expenses and other current assets 453 190
Total current assets 27,193 32,169
Operating lease right-of-use asset 237
Deposits 9
TOTAL ASSETS 27,439 32,169
Current liabilities    
Accounts payable 8,113 8,220
Accrued expenses 1,170 1,901
Current operating lease liability 100
Derivative liability 120 138
Total current liabilities 9,503 10,259
Non-current operating lease liability 147
Total liabilities 9,650 10,259
Stockholders’ equity    
Convertible Preferred stock
Common stock, par value $0.001, 750,000,000 shares authorized, 32,345,717 shares and 32,061,989 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 32 32
Common stock issuable 0 shares and 327,298 shares at March 31, 2022 and December 31, 2021, respectively 1,113
Additional paid in capital 676,780 674,348
Accumulated deficit (659,024) (653,584)
Total stockholders’ equity 17,789 21,910
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 27,439 32,169
Series C Preferred Stock [Member]    
Stockholders’ equity    
Convertible Preferred stock $ 1 $ 1